At present, the development of new drugs in China has gradually moved closer to the direction of original research and innovation in the true sense, and the high-quality development of the pharmaceutical industry has become the active choice under the new normal, and small molecule innovative drugs are the main force of drug development. Many excellent enterprises have emerged in China's small-molecule innovative drug industry, including old large-scale generic drug enterprises transforming to the research and development of innovative drugs, innovative drug enterprises achieving leapfrog development based on early technology accumulation and industrial upgrading or business model innovation, and a large number of clinical start-up drug enterprises participating in differentiated competition based on their different product categories and technology routes. Together to build a prosperous industry ecology. Today's small molecule new drug development forum, many companies based on the current situation, the future development trend of pharmaceutical companies were analyzed, but also shared the development progress of typical drugs within the enterprise.
